1. Home
  2. UBXG vs MBRX Comparison

UBXG vs MBRX Comparison

Compare UBXG & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U-BX Technology Ltd. Ordinary Shares

UBXG

U-BX Technology Ltd. Ordinary Shares

HOLD

Current Price

$1.93

Market Cap

66.0M

Sector

N/A

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$4.12

Market Cap

8.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UBXG
MBRX
Founded
2018
2015
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.0M
8.6M
IPO Year
2024
2016

Fundamental Metrics

Financial Performance
Metric
UBXG
MBRX
Price
$1.93
$4.12
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$105.50
AVG Volume (30 Days)
8.0K
598.7K
Earning Date
12-22-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,674,534.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.62
$3.13
52 Week High
$4.64
$91.25

Technical Indicators

Market Signals
Indicator
UBXG
MBRX
Relative Strength Index (RSI) 46.90 54.50
Support Level $1.93 $3.13
Resistance Level $2.08 $4.32
Average True Range (ATR) 0.10 0.34
MACD -0.00 -0.11
Stochastic Oscillator 33.50 78.51

Price Performance

Historical Comparison
UBXG
MBRX

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd focuses on providing value-added services using artificial intelligence-driven technology to businesses in the insurance industry, including insurance carriers and brokers. Its main offerings include three services/products: digital promotion services, risk assessment services, and value-added bundled benefits. The PRC operating entities help their institutional clients gain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or clients' promotion time on these channels. U-BX Beijing developed a unique algorithm named the Magic Mirror. The majority of revenue comes from digital promotion services. Geographically, all of the company's revenue is derived from Mainland China.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Share on Social Networks: